ELCURE

"Elcure, a company that leads cosmetics for patients and healing functional cosmetics"
As a nurse at Pusan National University Hospital for 20 years, he recognized and researched the correlation between harmful ingredients in cosmetics and diseases.
It succeeded in crowdfunding in 2018 and angel funding in 2019.
A step-by-step blueprint for listing is being prepared, and sales are expanding worldwide, including domestic dermatology, Thailand, Vietnam, and Russia.

"Elcure, a new paradigm for peptide cosmetics"
Peptide drugs have fewer side effects because they use peptides with excellent physiological activity. Peptide drugs can treat diseases even in very small amounts due to their strong activity and pharmacological action. The possibility of causing toxicity in vivo is relatively low and the amount of accumulation in living tissue is small, so the possibility of interaction between drugs is low.
Unlike retinol, peptide cosmetics do not accumulate or irritate the skin even when absorbed, and are highly safe as they are absorbed as proteins. Unlike collagen or botox, it can exert an effect on the epidermis, and because it is hydrophilic, it also has a moisturizing effect.
Elcure's peptide is a peptide that selectively increases type 1 collagen, the most core component of the dermis.